Marcus Ladds is an Associate Principal Scientist at AstraZeneca, specializing in mechanistic biology and profiling, with a focus on covalent drug discovery and mass spectrometry. Prior to this role, Marcus served as a Senior Research Scientist at Cancer Research UK's Beatson Institute and led a postdoctoral research group on pancreatic cancer biomarkers and multidrug resistance. Additional postdoctoral experience at Karolinska Institutet involved proteomics and mass spectrometry, contributing to the understanding of small molecules in tumor biology. Marcus holds a PhD in Oncology and Cancer Biology from Karolinska Institutet, as well as MSc and BSc degrees in Pharmacology, Toxicology, and Biomedical Sciences from the University of Auckland. Previous roles also include laboratory demonstrator and programme administrator.
This person is not in the org chart
This person is not in any teams
This person is not in any offices